nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—PTGS1—ulcerative colitis	0.161	0.501	CbGaD
Imatinib—ALB—ulcerative colitis	0.0818	0.255	CbGaD
Imatinib—ABCB1—ulcerative colitis	0.0781	0.244	CbGaD
Imatinib—PTGS1—Olsalazine—ulcerative colitis	0.037	0.0932	CbGbCtD
Imatinib—PTGS1—Balsalazide—ulcerative colitis	0.033	0.083	CbGbCtD
Imatinib—SLC22A2—Nicotine—ulcerative colitis	0.0278	0.07	CbGbCtD
Imatinib—PTGS1—Mesalazine—ulcerative colitis	0.0264	0.0664	CbGbCtD
Imatinib—SLC22A1—Nicotine—ulcerative colitis	0.0242	0.0608	CbGbCtD
Imatinib—ABCG2—Sulfasalazine—ulcerative colitis	0.016	0.0402	CbGbCtD
Imatinib—PTGS1—Sulfasalazine—ulcerative colitis	0.0147	0.0371	CbGbCtD
Imatinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0128	0.0322	CbGbCtD
Imatinib—CYP3A4—Budesonide—ulcerative colitis	0.0102	0.0256	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.00946	0.0238	CbGbCtD
Imatinib—CYP3A7—Hydrocortisone—ulcerative colitis	0.00946	0.0238	CbGbCtD
Imatinib—CYP2C19—Nicotine—ulcerative colitis	0.00917	0.0231	CbGbCtD
Imatinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.00884	0.0223	CbGbCtD
Imatinib—ALB—Prednisone—ulcerative colitis	0.0088	0.0221	CbGbCtD
Imatinib—CYP1A2—Nicotine—ulcerative colitis	0.00846	0.0213	CbGbCtD
Imatinib—CYP2C19—Cholecalciferol—ulcerative colitis	0.00823	0.0207	CbGbCtD
Imatinib—ABCG2—Dexamethasone—ulcerative colitis	0.00797	0.0201	CbGbCtD
Imatinib—CYP2C9—Nicotine—ulcerative colitis	0.00763	0.0192	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—ulcerative colitis	0.0076	0.0191	CbGbCtD
Imatinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.0071	0.0179	CbGbCtD
Imatinib—CYP2D6—Nicotine—ulcerative colitis	0.00697	0.0176	CbGbCtD
Imatinib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00684	0.0172	CbGbCtD
Imatinib—CYP2D6—Cholecalciferol—ulcerative colitis	0.00626	0.0157	CbGbCtD
Imatinib—KIT—myenteric nerve plexus—ulcerative colitis	0.00617	0.159	CbGeAlD
Imatinib—CYP3A7—Dexamethasone—ulcerative colitis	0.00588	0.0148	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.00588	0.0148	CbGbCtD
Imatinib—CYP2C19—Prednisone—ulcerative colitis	0.0057	0.0144	CbGbCtD
Imatinib—ABCB1—Betamethasone—ulcerative colitis	0.00494	0.0124	CbGbCtD
Imatinib—ABCB1—Prednisolone—ulcerative colitis	0.00487	0.0123	CbGbCtD
Imatinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00462	0.0116	CbGbCtD
Imatinib—ABCB1—Prednisone—ulcerative colitis	0.0046	0.0116	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00455	0.0115	CbGbCtD
Imatinib—CYP3A4—Nicotine—ulcerative colitis	0.00443	0.0112	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00441	0.0111	CbGbCtD
Imatinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00398	0.01	CbGbCtD
Imatinib—ORM1—bile—ulcerative colitis	0.00392	0.101	CbGeAlD
Imatinib—CYP2C19—Dexamethasone—ulcerative colitis	0.00356	0.00896	CbGbCtD
Imatinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00345	0.00868	CbGbCtD
Imatinib—CYP2C9—Dexamethasone—ulcerative colitis	0.00296	0.00745	CbGbCtD
Imatinib—CYP3A4—Betamethasone—ulcerative colitis	0.00296	0.00745	CbGbCtD
Imatinib—CYP3A4—Prednisolone—ulcerative colitis	0.00292	0.00735	CbGbCtD
Imatinib—ABCB1—Dexamethasone—ulcerative colitis	0.00287	0.00723	CbGbCtD
Imatinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00277	0.00697	CbGbCtD
Imatinib—CYP3A4—Prednisone—ulcerative colitis	0.00276	0.00694	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—ulcerative colitis	0.00271	0.00681	CbGbCtD
Imatinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00172	0.00433	CbGbCtD
Imatinib—DDR1—smooth muscle tissue—ulcerative colitis	0.00164	0.0422	CbGeAlD
Imatinib—DDR1—liver—ulcerative colitis	0.000962	0.0248	CbGeAlD
Imatinib—CA7—digestive system—ulcerative colitis	0.00083	0.0214	CbGeAlD
Imatinib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.00074	0.0191	CbGeAlD
Imatinib—CA9—digestive system—ulcerative colitis	0.000729	0.0188	CbGeAlD
Imatinib—CSF1R—smooth muscle tissue—ulcerative colitis	0.000651	0.0168	CbGeAlD
Imatinib—ABL2—liver—ulcerative colitis	0.000628	0.0162	CbGeAlD
Imatinib—KIT—epithelium—ulcerative colitis	0.000614	0.0158	CbGeAlD
Imatinib—PDGFRB—epithelium—ulcerative colitis	0.000599	0.0155	CbGeAlD
Imatinib—PIP4K2C—liver—ulcerative colitis	0.000594	0.0153	CbGeAlD
Imatinib—KIT—smooth muscle tissue—ulcerative colitis	0.000591	0.0153	CbGeAlD
Imatinib—PDGFRA—lymphoid tissue—ulcerative colitis	0.000591	0.0153	CbGeAlD
Imatinib—PDGFRA—digestive system—ulcerative colitis	0.000584	0.0151	CbGeAlD
Imatinib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000578	0.0149	CbGeAlD
Imatinib—CA3—liver—ulcerative colitis	0.000567	0.0146	CbGeAlD
Imatinib—SLC22A2—digestive system—ulcerative colitis	0.000555	0.0143	CbGeAlD
Imatinib—CA12—digestive system—ulcerative colitis	0.000539	0.0139	CbGeAlD
Imatinib—LCK—liver—ulcerative colitis	0.000527	0.0136	CbGeAlD
Imatinib—CSF1R—lymphoid tissue—ulcerative colitis	0.000521	0.0134	CbGeAlD
Imatinib—CA14—liver—ulcerative colitis	0.000515	0.0133	CbGeAlD
Imatinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000515	0.0133	CbGeAlD
Imatinib—CSF1R—digestive system—ulcerative colitis	0.000514	0.0133	CbGeAlD
Imatinib—CYP3A7—liver—ulcerative colitis	0.000504	0.013	CbGeAlD
Imatinib—KIT—lymphoid tissue—ulcerative colitis	0.000473	0.0122	CbGeAlD
Imatinib—SLC47A1—digestive system—ulcerative colitis	0.00047	0.0121	CbGeAlD
Imatinib—KIT—digestive system—ulcerative colitis	0.000467	0.0121	CbGeAlD
Imatinib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000462	0.0119	CbGeAlD
Imatinib—PDGFRB—digestive system—ulcerative colitis	0.000456	0.0118	CbGeAlD
Imatinib—NQO2—liver—ulcerative colitis	0.000436	0.0113	CbGeAlD
Imatinib—PDGFRA—liver—ulcerative colitis	0.000435	0.0112	CbGeAlD
Imatinib—CA1—lymphoid tissue—ulcerative colitis	0.000432	0.0112	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000428	0.0111	CbGeAlD
Imatinib—CA1—digestive system—ulcerative colitis	0.000427	0.011	CbGeAlD
Imatinib—ABL1—lymphoid tissue—ulcerative colitis	0.000411	0.0106	CbGeAlD
Imatinib—ABL1—digestive system—ulcerative colitis	0.000406	0.0105	CbGeAlD
Imatinib—CSF1R—liver—ulcerative colitis	0.000383	0.00989	CbGeAlD
Imatinib—CA2—epithelium—ulcerative colitis	0.000364	0.00939	CbGeAlD
Imatinib—CA2—smooth muscle tissue—ulcerative colitis	0.000351	0.00905	CbGeAlD
Imatinib—SLC47A1—liver—ulcerative colitis	0.00035	0.00903	CbGeAlD
Imatinib—KIT—liver—ulcerative colitis	0.000348	0.00898	CbGeAlD
Imatinib—PDGFRB—liver—ulcerative colitis	0.00034	0.00877	CbGeAlD
Imatinib—ORM1—liver—ulcerative colitis	0.000319	0.00823	CbGeAlD
Imatinib—CA1—liver—ulcerative colitis	0.000318	0.00821	CbGeAlD
Imatinib—ABL1—liver—ulcerative colitis	0.000303	0.00782	CbGeAlD
Imatinib—CYP2C19—digestive system—ulcerative colitis	0.000302	0.0078	CbGeAlD
Imatinib—SLC22A1—liver—ulcerative colitis	0.000292	0.00753	CbGeAlD
Imatinib—PTGS1—epithelium—ulcerative colitis	0.000281	0.00725	CbGeAlD
Imatinib—CA2—lymphoid tissue—ulcerative colitis	0.00028	0.00723	CbGeAlD
Imatinib—ALB—liver—ulcerative colitis	0.000279	0.00721	CbGeAlD
Imatinib—CA2—digestive system—ulcerative colitis	0.000277	0.00714	CbGeAlD
Imatinib—PTGS1—smooth muscle tissue—ulcerative colitis	0.000271	0.00699	CbGeAlD
Imatinib—CYP1A2—digestive system—ulcerative colitis	0.000247	0.00637	CbGeAlD
Imatinib—CYP3A5—digestive system—ulcerative colitis	0.000238	0.00614	CbGeAlD
Imatinib—CYP2C9—digestive system—ulcerative colitis	0.000234	0.00604	CbGeAlD
Imatinib—CYP2C19—liver—ulcerative colitis	0.000225	0.00581	CbGeAlD
Imatinib—Ponatinib—ABCB1—ulcerative colitis	0.000215	0.575	CrCbGaD
Imatinib—PTGS1—digestive system—ulcerative colitis	0.000214	0.00552	CbGeAlD
Imatinib—CA2—liver—ulcerative colitis	0.000206	0.00532	CbGeAlD
Imatinib—ABCG2—liver—ulcerative colitis	0.000191	0.00493	CbGeAlD
Imatinib—CYP1A2—liver—ulcerative colitis	0.000184	0.00474	CbGeAlD
Imatinib—CYP3A4—digestive system—ulcerative colitis	0.000179	0.00461	CbGeAlD
Imatinib—CYP3A5—liver—ulcerative colitis	0.000177	0.00457	CbGeAlD
Imatinib—CYP2D6—digestive system—ulcerative colitis	0.000176	0.00453	CbGeAlD
Imatinib—CYP2C9—liver—ulcerative colitis	0.000174	0.0045	CbGeAlD
Imatinib—ABCB1—epithelium—ulcerative colitis	0.000166	0.00429	CbGeAlD
Imatinib—Nilotinib—ABCB1—ulcerative colitis	0.000159	0.425	CrCbGaD
Imatinib—CYP3A4—liver—ulcerative colitis	0.000133	0.00343	CbGeAlD
Imatinib—CYP2D6—liver—ulcerative colitis	0.000131	0.00338	CbGeAlD
Imatinib—ABCB1—lymphoid tissue—ulcerative colitis	0.000128	0.0033	CbGeAlD
Imatinib—ABCB1—digestive system—ulcerative colitis	0.000126	0.00326	CbGeAlD
Imatinib—ABCB1—liver—ulcerative colitis	9.42e-05	0.00243	CbGeAlD
Imatinib—Myalgia—Methylprednisolone—ulcerative colitis	4.74e-05	0.000303	CcSEcCtD
Imatinib—Eye disorder—Prednisone—ulcerative colitis	4.74e-05	0.000303	CcSEcCtD
Imatinib—Anxiety—Methylprednisolone—ulcerative colitis	4.73e-05	0.000302	CcSEcCtD
Imatinib—Tachycardia—Hydrocortisone—ulcerative colitis	4.72e-05	0.000302	CcSEcCtD
Imatinib—Rash—Azathioprine—ulcerative colitis	4.71e-05	0.000301	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.71e-05	0.000301	CcSEcCtD
Imatinib—Dermatitis—Azathioprine—ulcerative colitis	4.71e-05	0.000301	CcSEcCtD
Imatinib—Flushing—Prednisone—ulcerative colitis	4.7e-05	0.000301	CcSEcCtD
Imatinib—Skin disorder—Hydrocortisone—ulcerative colitis	4.7e-05	0.000301	CcSEcCtD
Imatinib—Ill-defined disorder—Betamethasone—ulcerative colitis	4.7e-05	0.000301	CcSEcCtD
Imatinib—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.7e-05	0.000301	CcSEcCtD
Imatinib—Discomfort—Triamcinolone—ulcerative colitis	4.7e-05	0.0003	CcSEcCtD
Imatinib—Discomfort—Methylprednisolone—ulcerative colitis	4.69e-05	0.0003	CcSEcCtD
Imatinib—Headache—Azathioprine—ulcerative colitis	4.68e-05	0.000299	CcSEcCtD
Imatinib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.68e-05	0.000299	CcSEcCtD
Imatinib—Diarrhoea—Mesalazine—ulcerative colitis	4.66e-05	0.000298	CcSEcCtD
Imatinib—Dry mouth—Triamcinolone—ulcerative colitis	4.65e-05	0.000297	CcSEcCtD
Imatinib—Angioedema—Dexamethasone—ulcerative colitis	4.63e-05	0.000296	CcSEcCtD
Imatinib—Angioedema—Betamethasone—ulcerative colitis	4.63e-05	0.000296	CcSEcCtD
Imatinib—Anorexia—Hydrocortisone—ulcerative colitis	4.61e-05	0.000295	CcSEcCtD
Imatinib—Angiopathy—Prednisone—ulcerative colitis	4.6e-05	0.000294	CcSEcCtD
Imatinib—Confusional state—Methylprednisolone—ulcerative colitis	4.59e-05	0.000293	CcSEcCtD
Imatinib—Immune system disorder—Prednisone—ulcerative colitis	4.58e-05	0.000293	CcSEcCtD
Imatinib—Malaise—Dexamethasone—ulcerative colitis	4.57e-05	0.000292	CcSEcCtD
Imatinib—Malaise—Betamethasone—ulcerative colitis	4.57e-05	0.000292	CcSEcCtD
Imatinib—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.56e-05	0.000292	CcSEcCtD
Imatinib—Oedema—Triamcinolone—ulcerative colitis	4.56e-05	0.000292	CcSEcCtD
Imatinib—Vertigo—Betamethasone—ulcerative colitis	4.55e-05	0.000291	CcSEcCtD
Imatinib—Vertigo—Dexamethasone—ulcerative colitis	4.55e-05	0.000291	CcSEcCtD
Imatinib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.55e-05	0.000291	CcSEcCtD
Imatinib—Syncope—Dexamethasone—ulcerative colitis	4.54e-05	0.000291	CcSEcCtD
Imatinib—Syncope—Betamethasone—ulcerative colitis	4.54e-05	0.000291	CcSEcCtD
Imatinib—Arrhythmia—Prednisone—ulcerative colitis	4.53e-05	0.00029	CcSEcCtD
Imatinib—Infection—Triamcinolone—ulcerative colitis	4.53e-05	0.00029	CcSEcCtD
Imatinib—Hypotension—Hydrocortisone—ulcerative colitis	4.52e-05	0.000289	CcSEcCtD
Imatinib—Infection—Methylprednisolone—ulcerative colitis	4.52e-05	0.000289	CcSEcCtD
Imatinib—Dizziness—Mesalazine—ulcerative colitis	4.5e-05	0.000288	CcSEcCtD
Imatinib—Shock—Triamcinolone—ulcerative colitis	4.48e-05	0.000287	CcSEcCtD
Imatinib—Insomnia—Prednisolone—ulcerative colitis	4.48e-05	0.000287	CcSEcCtD
Imatinib—Alopecia—Prednisone—ulcerative colitis	4.48e-05	0.000287	CcSEcCtD
Imatinib—Shock—Methylprednisolone—ulcerative colitis	4.47e-05	0.000286	CcSEcCtD
Imatinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.46e-05	0.000285	CcSEcCtD
Imatinib—Loss of consciousness—Dexamethasone—ulcerative colitis	4.45e-05	0.000285	CcSEcCtD
Imatinib—Loss of consciousness—Betamethasone—ulcerative colitis	4.45e-05	0.000285	CcSEcCtD
Imatinib—Paraesthesia—Prednisolone—ulcerative colitis	4.45e-05	0.000285	CcSEcCtD
Imatinib—Tachycardia—Triamcinolone—ulcerative colitis	4.45e-05	0.000285	CcSEcCtD
Imatinib—Mental disorder—Prednisone—ulcerative colitis	4.44e-05	0.000284	CcSEcCtD
Imatinib—Nausea—Azathioprine—ulcerative colitis	4.44e-05	0.000284	CcSEcCtD
Imatinib—Tachycardia—Methylprednisolone—ulcerative colitis	4.44e-05	0.000284	CcSEcCtD
Imatinib—Skin disorder—Methylprednisolone—ulcerative colitis	4.42e-05	0.000283	CcSEcCtD
Imatinib—Malnutrition—Prednisone—ulcerative colitis	4.41e-05	0.000282	CcSEcCtD
Imatinib—Erythema—Prednisone—ulcerative colitis	4.41e-05	0.000282	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.41e-05	0.000282	CcSEcCtD
Imatinib—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.41e-05	0.000282	CcSEcCtD
Imatinib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.4e-05	0.000281	CcSEcCtD
Imatinib—Convulsion—Betamethasone—ulcerative colitis	4.39e-05	0.000281	CcSEcCtD
Imatinib—Convulsion—Dexamethasone—ulcerative colitis	4.39e-05	0.000281	CcSEcCtD
Imatinib—Insomnia—Hydrocortisone—ulcerative colitis	4.38e-05	0.00028	CcSEcCtD
Imatinib—Hypertension—Dexamethasone—ulcerative colitis	4.37e-05	0.00028	CcSEcCtD
Imatinib—Hypertension—Betamethasone—ulcerative colitis	4.37e-05	0.00028	CcSEcCtD
Imatinib—Paraesthesia—Hydrocortisone—ulcerative colitis	4.35e-05	0.000278	CcSEcCtD
Imatinib—Vomiting—Mesalazine—ulcerative colitis	4.33e-05	0.000277	CcSEcCtD
Imatinib—Myalgia—Dexamethasone—ulcerative colitis	4.31e-05	0.000276	CcSEcCtD
Imatinib—Myalgia—Betamethasone—ulcerative colitis	4.31e-05	0.000276	CcSEcCtD
Imatinib—Anxiety—Betamethasone—ulcerative colitis	4.3e-05	0.000275	CcSEcCtD
Imatinib—Anxiety—Dexamethasone—ulcerative colitis	4.3e-05	0.000275	CcSEcCtD
Imatinib—Rash—Mesalazine—ulcerative colitis	4.29e-05	0.000275	CcSEcCtD
Imatinib—Dermatitis—Mesalazine—ulcerative colitis	4.29e-05	0.000274	CcSEcCtD
Imatinib—Headache—Mesalazine—ulcerative colitis	4.26e-05	0.000273	CcSEcCtD
Imatinib—Discomfort—Dexamethasone—ulcerative colitis	4.26e-05	0.000273	CcSEcCtD
Imatinib—Discomfort—Betamethasone—ulcerative colitis	4.26e-05	0.000273	CcSEcCtD
Imatinib—Dyspepsia—Hydrocortisone—ulcerative colitis	4.26e-05	0.000273	CcSEcCtD
Imatinib—Hypotension—Methylprednisolone—ulcerative colitis	4.25e-05	0.000272	CcSEcCtD
Imatinib—Pain—Prednisolone—ulcerative colitis	4.24e-05	0.000271	CcSEcCtD
Imatinib—Decreased appetite—Hydrocortisone—ulcerative colitis	4.21e-05	0.000269	CcSEcCtD
Imatinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.18e-05	0.000267	CcSEcCtD
Imatinib—Fatigue—Hydrocortisone—ulcerative colitis	4.17e-05	0.000267	CcSEcCtD
Imatinib—Vision blurred—Prednisone—ulcerative colitis	4.16e-05	0.000266	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.15e-05	0.000266	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Pain—Hydrocortisone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Oedema—Betamethasone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Oedema—Dexamethasone—ulcerative colitis	4.14e-05	0.000265	CcSEcCtD
Imatinib—Insomnia—Triamcinolone—ulcerative colitis	4.12e-05	0.000264	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—ulcerative colitis	4.11e-05	0.000263	CcSEcCtD
Imatinib—Infection—Betamethasone—ulcerative colitis	4.11e-05	0.000263	CcSEcCtD
Imatinib—Infection—Dexamethasone—ulcerative colitis	4.11e-05	0.000263	CcSEcCtD
Imatinib—Ill-defined disorder—Prednisone—ulcerative colitis	4.09e-05	0.000262	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—ulcerative colitis	4.09e-05	0.000262	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—ulcerative colitis	4.08e-05	0.000261	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—ulcerative colitis	4.08e-05	0.000261	CcSEcCtD
Imatinib—Anaemia—Prednisone—ulcerative colitis	4.08e-05	0.000261	CcSEcCtD
Imatinib—Shock—Betamethasone—ulcerative colitis	4.07e-05	0.00026	CcSEcCtD
Imatinib—Shock—Dexamethasone—ulcerative colitis	4.07e-05	0.00026	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—ulcerative colitis	4.06e-05	0.00026	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—ulcerative colitis	4.06e-05	0.000259	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—ulcerative colitis	4.06e-05	0.000259	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.05e-05	0.000259	CcSEcCtD
Imatinib—Thrombocytopenia—Betamethasone—ulcerative colitis	4.05e-05	0.000259	CcSEcCtD
Imatinib—Nausea—Mesalazine—ulcerative colitis	4.04e-05	0.000259	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—ulcerative colitis	4.04e-05	0.000258	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—ulcerative colitis	4.04e-05	0.000258	CcSEcCtD
Imatinib—Angioedema—Prednisone—ulcerative colitis	4.03e-05	0.000258	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—ulcerative colitis	4.01e-05	0.000257	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—ulcerative colitis	4e-05	0.000256	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—ulcerative colitis	4e-05	0.000256	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—ulcerative colitis	4e-05	0.000256	CcSEcCtD
Imatinib—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.99e-05	0.000255	CcSEcCtD
Imatinib—Malaise—Prednisone—ulcerative colitis	3.98e-05	0.000255	CcSEcCtD
Imatinib—Vertigo—Prednisone—ulcerative colitis	3.96e-05	0.000254	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.96e-05	0.000253	CcSEcCtD
Imatinib—Syncope—Prednisone—ulcerative colitis	3.96e-05	0.000253	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—ulcerative colitis	3.94e-05	0.000252	CcSEcCtD
Imatinib—Anorexia—Betamethasone—ulcerative colitis	3.94e-05	0.000252	CcSEcCtD
Imatinib—Urticaria—Prednisolone—ulcerative colitis	3.94e-05	0.000252	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—ulcerative colitis	3.93e-05	0.000251	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—ulcerative colitis	3.92e-05	0.000251	CcSEcCtD
Imatinib—Pain—Triamcinolone—ulcerative colitis	3.9e-05	0.000249	CcSEcCtD
Imatinib—Loss of consciousness—Prednisone—ulcerative colitis	3.88e-05	0.000248	CcSEcCtD
Imatinib—Hypotension—Betamethasone—ulcerative colitis	3.86e-05	0.000247	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—ulcerative colitis	3.86e-05	0.000247	CcSEcCtD
Imatinib—Urticaria—Hydrocortisone—ulcerative colitis	3.85e-05	0.000246	CcSEcCtD
Imatinib—Body temperature increased—Hydrocortisone—ulcerative colitis	3.83e-05	0.000245	CcSEcCtD
Imatinib—Abdominal pain—Hydrocortisone—ulcerative colitis	3.83e-05	0.000245	CcSEcCtD
Imatinib—Convulsion—Prednisone—ulcerative colitis	3.82e-05	0.000245	CcSEcCtD
Imatinib—Hypertension—Prednisone—ulcerative colitis	3.81e-05	0.000244	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.77e-05	0.000241	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.77e-05	0.000241	CcSEcCtD
Imatinib—Arthralgia—Prednisone—ulcerative colitis	3.76e-05	0.00024	CcSEcCtD
Imatinib—Myalgia—Prednisone—ulcerative colitis	3.76e-05	0.00024	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—ulcerative colitis	3.76e-05	0.00024	CcSEcCtD
Imatinib—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.75e-05	0.00024	CcSEcCtD
Imatinib—Anxiety—Prednisone—ulcerative colitis	3.74e-05	0.000239	CcSEcCtD
Imatinib—Insomnia—Betamethasone—ulcerative colitis	3.74e-05	0.000239	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—ulcerative colitis	3.74e-05	0.000239	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.73e-05	0.000239	CcSEcCtD
Imatinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.72e-05	0.000238	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—ulcerative colitis	3.71e-05	0.000238	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—ulcerative colitis	3.71e-05	0.000238	CcSEcCtD
Imatinib—Discomfort—Prednisone—ulcerative colitis	3.71e-05	0.000237	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—ulcerative colitis	3.65e-05	0.000234	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—ulcerative colitis	3.64e-05	0.000233	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—ulcerative colitis	3.64e-05	0.000233	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—ulcerative colitis	3.62e-05	0.000232	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—ulcerative colitis	3.61e-05	0.000231	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Anaphylactic shock—Prednisone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Oedema—Prednisone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Abdominal pain—Methylprednisolone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—ulcerative colitis	3.6e-05	0.00023	CcSEcCtD
Imatinib—Infection—Prednisone—ulcerative colitis	3.58e-05	0.000229	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.57e-05	0.000228	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.57e-05	0.000228	CcSEcCtD
Imatinib—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.57e-05	0.000228	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—ulcerative colitis	3.57e-05	0.000228	CcSEcCtD
Imatinib—Fatigue—Betamethasone—ulcerative colitis	3.57e-05	0.000228	CcSEcCtD
Imatinib—Shock—Prednisone—ulcerative colitis	3.54e-05	0.000227	CcSEcCtD
Imatinib—Pain—Betamethasone—ulcerative colitis	3.54e-05	0.000226	CcSEcCtD
Imatinib—Pain—Dexamethasone—ulcerative colitis	3.54e-05	0.000226	CcSEcCtD
Imatinib—Nervous system disorder—Prednisone—ulcerative colitis	3.53e-05	0.000226	CcSEcCtD
Imatinib—Tachycardia—Prednisone—ulcerative colitis	3.52e-05	0.000225	CcSEcCtD
Imatinib—Skin disorder—Prednisone—ulcerative colitis	3.5e-05	0.000224	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisone—ulcerative colitis	3.48e-05	0.000223	CcSEcCtD
Imatinib—Asthenia—Hydrocortisone—ulcerative colitis	3.47e-05	0.000222	CcSEcCtD
Imatinib—Anorexia—Prednisone—ulcerative colitis	3.43e-05	0.00022	CcSEcCtD
Imatinib—Pruritus—Hydrocortisone—ulcerative colitis	3.42e-05	0.000219	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—ulcerative colitis	3.41e-05	0.000218	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—ulcerative colitis	3.41e-05	0.000218	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.38e-05	0.000216	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.38e-05	0.000216	CcSEcCtD
Imatinib—Hypersensitivity—Triamcinolone—ulcerative colitis	3.36e-05	0.000215	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.35e-05	0.000214	CcSEcCtD
Imatinib—Diarrhoea—Hydrocortisone—ulcerative colitis	3.31e-05	0.000212	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—ulcerative colitis	3.29e-05	0.00021	CcSEcCtD
Imatinib—Urticaria—Betamethasone—ulcerative colitis	3.29e-05	0.00021	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.28e-05	0.00021	CcSEcCtD
Imatinib—Dizziness—Prednisolone—ulcerative colitis	3.28e-05	0.00021	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—ulcerative colitis	3.27e-05	0.000209	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—ulcerative colitis	3.27e-05	0.000209	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—ulcerative colitis	3.27e-05	0.000209	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—ulcerative colitis	3.27e-05	0.000209	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—ulcerative colitis	3.27e-05	0.000209	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—ulcerative colitis	3.26e-05	0.000209	CcSEcCtD
Imatinib—Insomnia—Prednisone—ulcerative colitis	3.26e-05	0.000208	CcSEcCtD
Imatinib—Paraesthesia—Prednisone—ulcerative colitis	3.23e-05	0.000207	CcSEcCtD
Imatinib—Pruritus—Triamcinolone—ulcerative colitis	3.22e-05	0.000206	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—ulcerative colitis	3.22e-05	0.000206	CcSEcCtD
Imatinib—Dizziness—Hydrocortisone—ulcerative colitis	3.2e-05	0.000205	CcSEcCtD
Imatinib—Dyspepsia—Prednisone—ulcerative colitis	3.17e-05	0.000203	CcSEcCtD
Imatinib—Decreased appetite—Prednisone—ulcerative colitis	3.13e-05	0.0002	CcSEcCtD
Imatinib—Rash—Prednisolone—ulcerative colitis	3.12e-05	0.0002	CcSEcCtD
Imatinib—Dermatitis—Prednisolone—ulcerative colitis	3.12e-05	0.0002	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—ulcerative colitis	3.11e-05	0.000199	CcSEcCtD
Imatinib—Fatigue—Prednisone—ulcerative colitis	3.11e-05	0.000199	CcSEcCtD
Imatinib—Headache—Prednisolone—ulcerative colitis	3.1e-05	0.000199	CcSEcCtD
Imatinib—Constipation—Prednisone—ulcerative colitis	3.08e-05	0.000197	CcSEcCtD
Imatinib—Vomiting—Hydrocortisone—ulcerative colitis	3.08e-05	0.000197	CcSEcCtD
Imatinib—Rash—Hydrocortisone—ulcerative colitis	3.05e-05	0.000195	CcSEcCtD
Imatinib—Dermatitis—Hydrocortisone—ulcerative colitis	3.05e-05	0.000195	CcSEcCtD
Imatinib—Headache—Hydrocortisone—ulcerative colitis	3.03e-05	0.000194	CcSEcCtD
Imatinib—Dizziness—Triamcinolone—ulcerative colitis	3.01e-05	0.000193	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—ulcerative colitis	3.01e-05	0.000192	CcSEcCtD
Imatinib—Feeling abnormal—Prednisone—ulcerative colitis	2.97e-05	0.00019	CcSEcCtD
Imatinib—Asthenia—Dexamethasone—ulcerative colitis	2.97e-05	0.00019	CcSEcCtD
Imatinib—Asthenia—Betamethasone—ulcerative colitis	2.97e-05	0.00019	CcSEcCtD
Imatinib—Gastrointestinal pain—Prednisone—ulcerative colitis	2.95e-05	0.000188	CcSEcCtD
Imatinib—Nausea—Prednisolone—ulcerative colitis	2.94e-05	0.000188	CcSEcCtD
Imatinib—Pruritus—Betamethasone—ulcerative colitis	2.93e-05	0.000187	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—ulcerative colitis	2.93e-05	0.000187	CcSEcCtD
Imatinib—Vomiting—Triamcinolone—ulcerative colitis	2.9e-05	0.000185	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—ulcerative colitis	2.89e-05	0.000185	CcSEcCtD
Imatinib—Nausea—Hydrocortisone—ulcerative colitis	2.88e-05	0.000184	CcSEcCtD
Imatinib—Rash—Triamcinolone—ulcerative colitis	2.87e-05	0.000184	CcSEcCtD
Imatinib—Dermatitis—Triamcinolone—ulcerative colitis	2.87e-05	0.000184	CcSEcCtD
Imatinib—Rash—Methylprednisolone—ulcerative colitis	2.87e-05	0.000183	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—ulcerative colitis	2.86e-05	0.000183	CcSEcCtD
Imatinib—Urticaria—Prednisone—ulcerative colitis	2.86e-05	0.000183	CcSEcCtD
Imatinib—Headache—Triamcinolone—ulcerative colitis	2.86e-05	0.000183	CcSEcCtD
Imatinib—Headache—Methylprednisolone—ulcerative colitis	2.85e-05	0.000182	CcSEcCtD
Imatinib—Abdominal pain—Prednisone—ulcerative colitis	2.85e-05	0.000182	CcSEcCtD
Imatinib—Body temperature increased—Prednisone—ulcerative colitis	2.85e-05	0.000182	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—ulcerative colitis	2.83e-05	0.000181	CcSEcCtD
Imatinib—Diarrhoea—Dexamethasone—ulcerative colitis	2.83e-05	0.000181	CcSEcCtD
Imatinib—Dizziness—Betamethasone—ulcerative colitis	2.73e-05	0.000175	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—ulcerative colitis	2.73e-05	0.000175	CcSEcCtD
Imatinib—Nausea—Triamcinolone—ulcerative colitis	2.71e-05	0.000173	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—ulcerative colitis	2.7e-05	0.000173	CcSEcCtD
Imatinib—Hypersensitivity—Prednisone—ulcerative colitis	2.65e-05	0.00017	CcSEcCtD
Imatinib—Vomiting—Betamethasone—ulcerative colitis	2.63e-05	0.000168	CcSEcCtD
Imatinib—Vomiting—Dexamethasone—ulcerative colitis	2.63e-05	0.000168	CcSEcCtD
Imatinib—Rash—Dexamethasone—ulcerative colitis	2.61e-05	0.000167	CcSEcCtD
Imatinib—Rash—Betamethasone—ulcerative colitis	2.61e-05	0.000167	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—ulcerative colitis	2.61e-05	0.000167	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—ulcerative colitis	2.61e-05	0.000167	CcSEcCtD
Imatinib—Headache—Dexamethasone—ulcerative colitis	2.59e-05	0.000166	CcSEcCtD
Imatinib—Headache—Betamethasone—ulcerative colitis	2.59e-05	0.000166	CcSEcCtD
Imatinib—Asthenia—Prednisone—ulcerative colitis	2.58e-05	0.000165	CcSEcCtD
Imatinib—Pruritus—Prednisone—ulcerative colitis	2.55e-05	0.000163	CcSEcCtD
Imatinib—Diarrhoea—Prednisone—ulcerative colitis	2.46e-05	0.000158	CcSEcCtD
Imatinib—Nausea—Dexamethasone—ulcerative colitis	2.46e-05	0.000157	CcSEcCtD
Imatinib—Nausea—Betamethasone—ulcerative colitis	2.46e-05	0.000157	CcSEcCtD
Imatinib—Dizziness—Prednisone—ulcerative colitis	2.38e-05	0.000152	CcSEcCtD
Imatinib—Vomiting—Prednisone—ulcerative colitis	2.29e-05	0.000146	CcSEcCtD
Imatinib—Rash—Prednisone—ulcerative colitis	2.27e-05	0.000145	CcSEcCtD
Imatinib—Dermatitis—Prednisone—ulcerative colitis	2.27e-05	0.000145	CcSEcCtD
Imatinib—Headache—Prednisone—ulcerative colitis	2.26e-05	0.000144	CcSEcCtD
Imatinib—Nausea—Prednisone—ulcerative colitis	2.14e-05	0.000137	CcSEcCtD
Imatinib—KIT—Signaling Pathways—ADCY5—ulcerative colitis	6.64e-06	7.66e-05	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	6.59e-06	7.61e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—ulcerative colitis	6.57e-06	7.58e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	6.49e-06	7.49e-05	CbGpPWpGaD
Imatinib—LCK—Disease—ADCY5—ulcerative colitis	6.49e-06	7.49e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—GHRL—ulcerative colitis	6.47e-06	7.46e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	6.43e-06	7.42e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—JAK2—ulcerative colitis	6.4e-06	7.39e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ADCY5—ulcerative colitis	6.29e-06	7.25e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IFNG—ulcerative colitis	6.28e-06	7.25e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CALM3—ulcerative colitis	6.26e-06	7.23e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDH1—ulcerative colitis	6.23e-06	7.19e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—RELA—ulcerative colitis	6.2e-06	7.16e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RIPK2—ulcerative colitis	6.17e-06	7.12e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CRP—ulcerative colitis	6.15e-06	7.1e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NFKB1—ulcerative colitis	6.14e-06	7.09e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTGS2—ulcerative colitis	6.11e-06	7.05e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.08e-06	7.01e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDH1—ulcerative colitis	6.07e-06	7e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—ulcerative colitis	6.07e-06	7e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	6.06e-06	7e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—JAK2—ulcerative colitis	6.06e-06	6.99e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IFNG—ulcerative colitis	5.95e-06	6.87e-05	CbGpPWpGaD
Imatinib—KIT—Disease—JAK2—ulcerative colitis	5.91e-06	6.82e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NFKB1—ulcerative colitis	5.9e-06	6.81e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR4—ulcerative colitis	5.9e-06	6.8e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-DRB1—ulcerative colitis	5.89e-06	6.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—RELA—ulcerative colitis	5.87e-06	6.77e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS1—ulcerative colitis	5.78e-06	6.66e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—ulcerative colitis	5.75e-06	6.63e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TGFB1—ulcerative colitis	5.69e-06	6.56e-05	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—ulcerative colitis	5.68e-06	6.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ADCY5—ulcerative colitis	5.66e-06	6.53e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—ICAM1—ulcerative colitis	5.65e-06	6.52e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—JAK2—ulcerative colitis	5.65e-06	6.52e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ABCB1—ulcerative colitis	5.64e-06	6.51e-05	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—ulcerative colitis	5.64e-06	6.5e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL1B—ulcerative colitis	5.61e-06	6.47e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—ulcerative colitis	5.6e-06	6.47e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—JAK2—ulcerative colitis	5.6e-06	6.46e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCB1—ulcerative colitis	5.59e-06	6.46e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCB1—ulcerative colitis	5.59e-06	6.45e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—ulcerative colitis	5.58e-06	6.44e-05	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—ulcerative colitis	5.56e-06	6.42e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DLD—ulcerative colitis	5.55e-06	6.41e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RELA—ulcerative colitis	5.47e-06	6.31e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—JAK2—ulcerative colitis	5.46e-06	6.3e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.44e-06	6.28e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCB1—ulcerative colitis	5.42e-06	6.26e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—ulcerative colitis	5.36e-06	6.19e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ADRB2—ulcerative colitis	5.35e-06	6.18e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	5.34e-06	6.17e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—ulcerative colitis	5.34e-06	6.16e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—JAK2—ulcerative colitis	5.32e-06	6.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL1B—ulcerative colitis	5.31e-06	6.12e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—ulcerative colitis	5.3e-06	6.12e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—ulcerative colitis	5.3e-06	6.12e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—RELA—ulcerative colitis	5.29e-06	6.1e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—ulcerative colitis	5.29e-06	6.1e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—ulcerative colitis	5.27e-06	6.08e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ADCY5—ulcerative colitis	5.27e-06	6.08e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKB1—ulcerative colitis	5.23e-06	6.04e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—ulcerative colitis	5.22e-06	6.03e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ADCY5—ulcerative colitis	5.22e-06	6.02e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ADCY5—ulcerative colitis	5.21e-06	6.01e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCB1—ulcerative colitis	5.21e-06	6.01e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	5.2e-06	6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—ulcerative colitis	5.18e-06	5.97e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL8—ulcerative colitis	5.16e-06	5.95e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—RELA—ulcerative colitis	5.15e-06	5.95e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ADCY5—ulcerative colitis	5.06e-06	5.84e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—ulcerative colitis	5.04e-06	5.82e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—JAK2—ulcerative colitis	5.04e-06	5.82e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CDH1—ulcerative colitis	5e-06	5.77e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—JAK2—ulcerative colitis	5e-06	5.76e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS1—ulcerative colitis	4.97e-06	5.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKB1—ulcerative colitis	4.95e-06	5.71e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—ulcerative colitis	4.93e-06	5.69e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.88e-06	5.64e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ADCY5—ulcerative colitis	4.86e-06	5.6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—ulcerative colitis	4.81e-06	5.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—ulcerative colitis	4.78e-06	5.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—ulcerative colitis	4.78e-06	5.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—ulcerative colitis	4.76e-06	5.5e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—ulcerative colitis	4.74e-06	5.47e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—STAT3—ulcerative colitis	4.7e-06	5.42e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—ulcerative colitis	4.68e-06	5.41e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—ulcerative colitis	4.68e-06	5.4e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MMP9—ulcerative colitis	4.66e-06	5.38e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—ulcerative colitis	4.66e-06	5.38e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—ulcerative colitis	4.64e-06	5.36e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKB1—ulcerative colitis	4.61e-06	5.33e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	4.54e-06	5.24e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CALM3—ulcerative colitis	4.48e-06	5.17e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	4.46e-06	5.15e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKB1—ulcerative colitis	4.46e-06	5.15e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.45e-06	5.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—STAT3—ulcerative colitis	4.45e-06	5.13e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.39e-06	5.07e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—JAK2—ulcerative colitis	4.38e-06	5.06e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	4.36e-06	5.03e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—ulcerative colitis	4.36e-06	5.03e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKB1—ulcerative colitis	4.35e-06	5.02e-05	CbGpPWpGaD
Imatinib—KIT—Disease—STAT3—ulcerative colitis	4.34e-06	5.01e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—ulcerative colitis	4.3e-06	4.96e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.28e-06	4.94e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—RELA—ulcerative colitis	4.24e-06	4.9e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—ulcerative colitis	4.15e-06	4.79e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—STAT3—ulcerative colitis	4.15e-06	4.79e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—JAK2—ulcerative colitis	4.14e-06	4.78e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—STAT3—ulcerative colitis	4.11e-06	4.74e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.11e-06	4.74e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.08e-06	4.7e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	4.07e-06	4.7e-05	CbGpPWpGaD
Imatinib—LCK—Disease—JAK2—ulcerative colitis	4.05e-06	4.67e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	4.04e-06	4.67e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—ulcerative colitis	4.02e-06	4.64e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CALM3—ulcerative colitis	4.02e-06	4.64e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RELA—ulcerative colitis	4.01e-06	4.63e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—STAT3—ulcerative colitis	4.01e-06	4.63e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4e-06	4.62e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARG—ulcerative colitis	3.93e-06	4.53e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CALM3—ulcerative colitis	3.92e-06	4.53e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	3.92e-06	4.52e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—STAT3—ulcerative colitis	3.91e-06	4.51e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARG—ulcerative colitis	3.89e-06	4.49e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARG—ulcerative colitis	3.89e-06	4.48e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—ulcerative colitis	3.86e-06	4.45e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—ulcerative colitis	3.84e-06	4.44e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.84e-06	4.43e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—ulcerative colitis	3.84e-06	4.43e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—ulcerative colitis	3.84e-06	4.43e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—ulcerative colitis	3.82e-06	4.41e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—ulcerative colitis	3.81e-06	4.39e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—ulcerative colitis	3.81e-06	4.39e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.81e-06	4.39e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	3.8e-06	4.38e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	3.78e-06	4.36e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARG—ulcerative colitis	3.77e-06	4.35e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	3.77e-06	4.35e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—STAT3—ulcerative colitis	3.7e-06	4.27e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.7e-06	4.27e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.67e-06	4.23e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARG—ulcerative colitis	3.62e-06	4.18e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—ulcerative colitis	3.61e-06	4.17e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKB1—ulcerative colitis	3.58e-06	4.13e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	3.58e-06	4.13e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—ulcerative colitis	3.53e-06	4.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	3.53e-06	4.07e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.5e-06	4.04e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—ulcerative colitis	3.5e-06	4.04e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—ulcerative colitis	3.49e-06	4.03e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCB1—ulcerative colitis	3.48e-06	4.02e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.48e-06	4.01e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—ulcerative colitis	3.43e-06	3.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.42e-06	3.95e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	3.42e-06	3.95e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	3.42e-06	3.94e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP9—ulcerative colitis	3.42e-06	3.94e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—ulcerative colitis	3.4e-06	3.92e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—ulcerative colitis	3.39e-06	3.91e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	3.38e-06	3.9e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—ulcerative colitis	3.28e-06	3.79e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—ulcerative colitis	3.26e-06	3.76e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADCY5—ulcerative colitis	3.25e-06	3.75e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	3.23e-06	3.73e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	3.22e-06	3.72e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—STAT3—ulcerative colitis	3.22e-06	3.71e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	3.2e-06	3.69e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—ulcerative colitis	3.16e-06	3.65e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CALM3—ulcerative colitis	3.13e-06	3.61e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	3.13e-06	3.61e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—ulcerative colitis	3.11e-06	3.59e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	3.09e-06	3.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	3.08e-06	3.55e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—ulcerative colitis	3.06e-06	3.53e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—ulcerative colitis	3.06e-06	3.53e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—STAT3—ulcerative colitis	3.04e-06	3.51e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—ulcerative colitis	3.03e-06	3.5e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.99e-06	3.45e-05	CbGpPWpGaD
Imatinib—LCK—Disease—STAT3—ulcerative colitis	2.97e-06	3.43e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.97e-06	3.42e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	2.92e-06	3.37e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	2.91e-06	3.36e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—ulcerative colitis	2.9e-06	3.34e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	2.88e-06	3.33e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	2.88e-06	3.32e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	2.88e-06	3.32e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—ulcerative colitis	2.87e-06	3.31e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.85e-06	3.29e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—ulcerative colitis	2.85e-06	3.29e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	2.85e-06	3.28e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—JAK2—ulcerative colitis	2.83e-06	3.27e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	2.82e-06	3.25e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	2.81e-06	3.25e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—ulcerative colitis	2.8e-06	3.23e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—ulcerative colitis	2.8e-06	3.23e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—ulcerative colitis	2.75e-06	3.18e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RELA—ulcerative colitis	2.74e-06	3.17e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—ulcerative colitis	2.73e-06	3.15e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.68e-06	3.1e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.68e-06	3.1e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	2.67e-06	3.08e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.66e-06	3.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	2.59e-06	2.99e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	2.59e-06	2.98e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—ulcerative colitis	2.58e-06	2.98e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—ulcerative colitis	2.53e-06	2.92e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—ulcerative colitis	2.47e-06	2.85e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.44e-06	2.81e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—ulcerative colitis	2.42e-06	2.8e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.42e-06	2.79e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	2.4e-06	2.77e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—ulcerative colitis	2.34e-06	2.7e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—ulcerative colitis	2.32e-06	2.68e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	2.31e-06	2.67e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.27e-06	2.62e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—ulcerative colitis	2.25e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	2.21e-06	2.55e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	2.19e-06	2.53e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—ulcerative colitis	2.18e-06	2.51e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—ulcerative colitis	2.12e-06	2.45e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—ulcerative colitis	2.12e-06	2.45e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—STAT3—ulcerative colitis	2.08e-06	2.4e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—ulcerative colitis	2.07e-06	2.39e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	2.01e-06	2.32e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2e-06	2.31e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.98e-06	2.29e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	1.98e-06	2.28e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—ulcerative colitis	1.96e-06	2.26e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	1.93e-06	2.22e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—ulcerative colitis	1.91e-06	2.2e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—ulcerative colitis	1.91e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.88e-06	2.17e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	1.81e-06	2.09e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—ulcerative colitis	1.8e-06	2.08e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—ulcerative colitis	1.78e-06	2.06e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.75e-06	2.02e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	1.71e-06	1.97e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.69e-06	1.96e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.67e-06	1.93e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—ulcerative colitis	1.59e-06	1.83e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.57e-06	1.82e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.56e-06	1.8e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—ulcerative colitis	1.52e-06	1.76e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—ulcerative colitis	1.45e-06	1.68e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.33e-06	1.54e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.31e-06	1.51e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.18e-06	1.36e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.03e-06	1.19e-05	CbGpPWpGaD
